(Q50304226)

2 March 2018

title

A crossover study of risperidone in children, adolescents and adults with mental retardation. (English)

1 reference

2 March 2018

1 reference

1 reference

Jessica A Hellings

1

1 reference

2 March 2018

Jennifer R Zarcone

2

1 reference

2 March 2018

R Matthew Reese

3

1 reference

2 March 2018

Maria G Valdovinos

4

1 reference

2 March 2018

Janet G Marquis

5

1 reference

2 March 2018

Kandace K Fleming

6

1 reference

2 March 2018

Stephen R Schroeder

7

1 reference

2 March 2018

language of work or name

English

0 references

publication date

1 April 2006

1 reference

2 March 2018

Journal of Autism and Developmental Disorders

published in

1 reference

2 March 2018

volume

36

1 reference

2 March 2018

issue

3

1 reference

2 March 2018

page(s)

401-411

1 reference

2 March 2018

https://scigraph.springernature.com/pub.10.1007/s10803-006-0078-1

exact match

0 references

cites work

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10803-006-0078-1

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10803-006-0078-1

The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10803-006-0078-1

Psychometric properties of the Dyskinesia Identification System: Condensed User Scale (DISCUS)

21 January 2018

1 reference

12 December 2020

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders

1 reference

12 December 2020

Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.

1 reference

12 December 2020

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

1 reference

12 December 2020

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children

1 reference

12 December 2020

Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures

1 reference

12 December 2020

Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder

1 reference

12 December 2020

Brief report: reliability and validity of instruments for assessing psychotropic medication effects on self-injurious behavior in mental retardation.

1 reference

12 December 2020

The serotonin system in autism

1 reference

12 December 2020

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

12 December 2020

Evidence of linkage between the serotonin transporter and autistic disorder.

1 reference

12 December 2020

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

1 reference

12 December 2020

Risperidone in children with autism and serious behavioral problems

1 reference

12 December 2020

1 reference

12 December 2020

Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders

1 reference

12 December 2020

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism

1 reference

12 December 2020

10.1007/S10803-006-0078-1

Identifiers

DOI

1 reference

2 March 2018

1 reference

2 March 2018